SIGN IN YOUR ACCOUNT TO HAVE ACCESS TO DIFFERENT FEATURES

FORGOT YOUR PASSWORD?

FORGOT YOUR DETAILS?

AAH, WAIT, I REMEMBER NOW!

Mario Randholm

  • LOGIN
  • Home
    • Team Experience
      • Mario Randholm
  • Blog
  • Resources
    • Partners
      • Thomson Reuters
      • MultiCharts
      • Municipalidad de Miraflores
      • TradingDiary Pro
    • AutoTradingAutoTrading
    • R Option ModelModel
    • Historical Performance
    • Comparison Matrix
  • Memberships
  • FAQ
    • Term of Service
Contact Us
  • Home
  • Blog
  • Market Update
  • News

News

randholm
February 18, 2014 12:14 pm / Published in Market Update

News

Stocks Mixed as Wall Street Cathces up with Overseas Markets!

U.S. equities snapped back to highs after probing session lows following the disappointment over the NAHB plunged in Feb, which was partly forgiven by investors after weather and "supply chain" effects, though the slant of the data continues to be downward. Perhaps that will continue to buy some relief from the Fed taper, as bad becomes good again. This is being led by NASDAQ, which is up 0.6%, which has dragged the blue chips back into positive territory. Pharmaceutical stocks are advancing after one of the companies in the sector, Forest Laboratories (FRX), agreed to be acquired by generic drug manufacturer Actavis (ACT). Meanwhile, pharmaceutical delivery company McKesson (MCK) and Rite Aid announced that McKesson would begin sourcing and distributing generic drugs to Rite Aid. WHAT’S NEW: Forest Laboratories, which develops branded drugs, agreed to sell itself to Actavis for about $25B, or $89.48 per share, the two companies announced earlier this morning. The purchase price represents a premium of about 25% per share over Forest’s stock price as of the close of trading on February 14, the companies stated. Actavis will pay the purchase price using a combination of cash and stock, the companies noted. Separately, McKesson and Rite Aid announced that McKesson would begin sourcing and distributing generic drugs for Rite Aid. The two companies previously had a wholesaling and distribution deal that did not include the sourcing and distribution of generics.

Check your inbox or spam folder to confirm your subscription.

Categories

Twitter

Lightning fast alerts:

twitter.com/MarioRandholm

twitter.com/RandBots

Archives

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy

ABOUT US

Mario Randholm Blog. Mario is the founder of Randholm & Co. S.A.C., an investment management company dedicated to producing superior returns for its clients and employees by adhering to mathematical and statistical methods.

CONTACT US

Message us

Mario's Linkedin

Past performance is no guarantee of future results.

Disclaimer:

This site is for informational purposes only. Nothing on this site should be considered investment advice or as a solicitation to buy or sell any security.

Please see our full Disclaimer.

TOP